David Gandara, Co-Director of the Center for Experimental Therapeutics at the UC Davis Comprehensive Cancer Center, shared on X:
“Lung MAP update by chair Karen Reckamp, Public-private partnership for drug development in NSCLC, through Foundation NIH.
Over ~6,000 patients enrolled, 16 trials, ~10,000 specimens for translational science studies. Happy Birthday Lung MAP! 10 years young!”